Tuula Kristiina Moilanen

Anthra Pharmaceuticals, Inc. is an American company.

Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom.

KuDOS Pharmaceuticals Ltd. discovers and develops pharmaceutical products. Its products are used to treat DNA damage sensing, signaling, viral disease, ischaemia, and repair to address unmet medical needs in cancer treatment. The company was founded by Stephen Jackson on December 12, 1997 and is headquartered in Cambridge, UK.

Lumora Ltd. provides molecular diagnostic products for the clinical and industrial markets. The company was founded by Laurence Carlo Tisi and James A. H. Murray in 2002 and is headquartered in Cambridge, the United Kingdom.

The Institute of Directors provides informative events and professional development courses. The non-profit company is based in Johannesburg, South Africa. Parmesvari Natesan has been the CEO of the South African company since 2010.

Summit (Cambridge) Ltd. develops and manufactures drugs and pharmaceuticals. It discovers and develops therapeutics for neurological, ophthalmologic, metabolic, and gastrointestinal diseases. The company was founded in 2001 by Paul Goldsmith and Mark Carlton and is headquartered in Cambridge, the United Kingdom.

Part of AbbVie, Inc., Epidauros Biotechnologie AG is a German company that specializes in pharmacogenomics research. The company is based in Bernried, Germany. Epidauros Biotechnologie was acquired by Clinical Data BV from Deutsche Effecten & Wechsel Beteiligungs AG on August 23, 2007 for $11.83 million.

Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines.

Paras Ltd. provides information management and strategy consultancy services to the energy sector. The company was founded by Hamish Angus Munro Wilson in 1993 and is headquartered in Abingdon, the United Kingdom.

MedImmune Pharma BV develops, manufactures and markets formulations for use in immunization programs. It specializes in the production of a vaccine called Amifostine. The company was founded in 1993 and is headquartered in Nijmegen, Belgium.

Founded in 1929, Glaxo Laboratories Ltd. is a pharmaceutical wholesaler that is part of GSK Plc. The company is based in London, UK.

Tokamak Energy Ltd. provides medical and biotechnology services. It develops the potential to use fusion neutrons for a variety of applications from material treatments to medical applications or low cost hydrogen production. The company was founded by David Richard Kingham, Mikhail Gryaznevich and Alan Sykes in 2009 and is headquartered in Abingdon, the United Kingdom.

Solent NHS Trust provides trust services. The non-profit company is based in Millbrook, UK. Sue Harriman has been the CEO of the British company since 2014.

Privitar Ltd. develops products for privacy preserving data mining and sophisticated data anonymization. It offers privacy-preserving data mining, protect against re-identification or differential privacy attacks, policy driven, consistent risk management, native support for big data and background services. The company was founded by Jason du Preez, John G. Taysom and Gerard Buggy in 2015 and is headquartered in London, the United Kingdom.

Spirogen SARL is a Swiss company. 'The private company is based in Lausanne, Switzerland. The company was founded by Christopher John Martin.

Transcriptogen Ltd. operates as a drug discovery company to exploit the use of small molecules to inhibit the interaction of transcription factors (TFs) with their cognate DNA-recognition site, thus down-regulating or inhibiting the transcription of disease-related genes. The firm develops and discovers anti-cancer drugs. The company was founded by Khondaker Miraz Rahman, Paul Jackson, and Sheraz Gul and is headquartered in Bath, the United Kingdom.

Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France.

Tagworks Pharmaceuticals BV is a Dutch precision therapy company that develops a new standard of care for patients suffering from severe diseases, including cancer. Tagworks Pharmaceuticals is based in and the Netherlands. The company leverages its technology platform, which is protected by a broad patent estate, to pioneer the click-to-release approach. Tagworks is developing a pipeline of click-cleavable therapies, including its lead program, TGW101, an antibody-drug conjugate targeting TAG72. The company's technology enables on-target activation of ADCs and immunomodulators, as well as off-target deactivation of radioimmunotherapies to enhance their therapeutic index. The company was founded in 2011 by Raffaella Rossin, Zach Taylor, Marc Robillard, and Marc Robillard has been the CEO since 2011.

Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom.

Pheon Therapeutics Ltd. is an antibody drug conjugate (ADC) specialist that develops a pipeline of monotherapies for novel targets and/or with novel payloads. The company is based in Harpdenden, UK. The British company's lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types. ADCs offer the potential to treat solid tumors and liquid cancers that have not responded to other treatments. The company was founded in 2015 by Paul Jackson. Cyrus D. Mozayeni has been the CEO of the company since 2023.